Sort
130,381 grants matching “hiv”
Acute HIV Infection: Implications for vaccine design
$2,689,363Marcus Altfeld · Massachusetts General Hospital · P01 · FY2010 · AI
Development of rationally designed HIV vaccines
$2,689,105Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Defining the cell-specific epigenetic landscape leading to altered gene expression signatures in HIV-Associated Neurocognitive Disorder
$2,688,892Christopher K Glass · University Of California, San Diego · RF1 · FY2018 · AG
Centers for AIDS Research (CFAR)
$2,688,655Georgia D Tomaras · Duke University · P30 · FY2022 · AI
ASSESSING ADM SERVICE NEEDS AMONG JUVENILE DETAINEES
$2,688,252Northwestern University · R01 · FY2001 · MH
Alternative Formulations of Tenofovir and UC781
$2,687,806Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2012 · AI
SUPPORT UGANDA MINISTRY OF HEALTH'S CAPACITY TO ADDRESS HIV RESPONSE THROUGH STRE
$2,686,824Jane Aceng · Aids Control Programme · U2G · FY2012 · GH
Viral Replication and Interactions with Host Factors
$2,686,663Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Drug at the Right Place & Concentration: Optimizing Combination Vaginal Ring Pr*
$2,686,508Betsy C. Herold · Albert Einstein College Of Medicine · U19 · FY2014 · AI
SUPPORTING TANZANIA TO EXPAND, STRENGTHEN & SUBSTAIN HIGH QUALITY HIV COUNSELING
$2,686,297James McMahan · Intrahealth International, Inc. · U2G · FY2013 · GH
NIAID HIV VACCINE RESEARCH EDUCATION INITIATIVE
$2,685,906Cornelius Baker · · N01 · FY2007 · AI
Evaluation of NIAID's HIV Vaccine Research Education Initiative
$2,685,906 · N01 · FY2007 · AI
Translational Methamphetamine AIDS Research Center (TMARC)
$2,685,904Igor Grant · University Of California, San Diego · P50 · FY2009 · DA
Mucosal Discovery Team
$2,685,822Thomas N Denny · Duke University · U19 · FY2008 · AI
Alcohol Associated Outcomes Among HIV+/-Aging Veterans
$2,685,761Yale University · U01 · FY2004 · AA
Multilevel Influences on HIV and Substance Use in a YMSM cohort
$2,685,262Brian Mustanski · Northwestern University At Chicago · U01 · FY2020 · DA
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION,CARE A
$2,685,000Dr. Anthony Amoroso · University Of Maryland Baltimore · U2G · FY2011 · PS
Smart Steps: A context-aware adherence intervention to improve PrEP adherence among men who have sex with men (MSM) with substance use disorder
$2,685,000Peter R Chai · Brigham And Women'S Hospital · DP2 · FY2022 · DA
Preventive Vaccines for HIV
$2,684,061Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
$2,683,830Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
Membrane Remodeling in Viral Infection and Assembly and Parasite Replication
$2,682,755Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
Impact Evaluation of Combination HIV Prevention Interventions in Botswana
$2,682,659Myron E Essex · Harvard School Of Public Health · U01 · FY2014 · GH
NIH-Owned Chimpanzee Research Resource at the SNPRC
$2,681,884John L Vandeberg · Texas Biomedical Research Institute · U42 · FY2012 · OD
PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS
$2,681,364William Lyons · Georgia Division Of Public Health · U62 · FY2010 · PS
Chemoprophylaxis for HIV Prevention in Men
$2,680,398Robert M. Grant · J. David Gladstone Institutes · U01 · FY2007 · AI